Protalix BioTherapeutics Inc Sustainability Reports
Protalix BioTherapeutics Inc. is a biopharmaceutical company focused on developing and manufacturing recombinant therapeutic proteins using its proprietary plant cell-based expression system.
Sector: Health Care
Country: United States
Exchange: NYSE American
ISIN: US74365A3095
5 reports from 2007 to 2024
Company Profile
Protalix BioTherapeutics Inc
Protalix BioTherapeutics Inc. is a biopharmaceutical company focused on developing and manufacturing recombinant therapeutic proteins using its proprietary plant cell-based expression system.
Reports